BrunoSan Finance Intelligence · May 13, 2026
Finance Intelligence News
Every article includes an Intel Score breakdown — so you know exactly how strong each signal is and where it came from. Not editorial judgment. Signal mathematics.
🏦 RATE DECISION
1.000
Iran War Inflationary Shock Resets Fed Policy, Complicates Path for Nominee Warsh
The inflationary shock from the Iran conflict has effectively removed rate cuts from the 2026 agenda, with markets now pricing less than a 15% probability of an ease before year-end and creating a severe stagflationary test for potential Federal Reserve Chair nominee Kevin Warsh.
🏦 RATE DECISION
1.000
Gold Declines as Hawkish Fed Repricing Accelerates on Inflation Jump
Gold (GC) declined for a second session after an unexpected jump in US inflation data forced markets to price in a 75% probability of a 25 basis point Federal Reserve rate hike. The repricing drove the 2-year Treasury yield up by 18 basis points, lifting real yields and directly undermining the investment case for non-yielding bullion.
📊 EARNINGS
1.000
TCS Earnings Miss Ignites Indian Tech Rout as Austerity Measures Bite
Tata Consultancy Services' unexpected 7.1% Q4 EPS miss has triggered a severe rout in India's tech sector, exposing its vulnerability to a global demand slowdown just as new domestic austerity measures constrict liquidity. The firm's slashed revenue guidance suggests a structural, not cyclical, headwind for the nation's largest export industry.
📊 EARNINGS
1.000
Hims & Hers Guidance Disappoints, Erasing 13% of Market Cap Post-Earnings
Hims & Hers (NYSE: HIMS) reported a net loss for Q1 2026 and issued Q2 revenue guidance below consensus, causing shares to fall 13% in after-hours trading despite the recent high-profile launch of its GLP-1 weight loss drug offering.
🔴 MARKET CRASH
1.000
US Retreat from Foundational Scientific Research Signals Long-Term Erosion of Market Leadership
The United States' pivot away from funding foundational scientific research represents a strategic misstep that cedes technological and economic advantage to China, threatening the long-term growth assumptions underpinning US equity valuations.